Sign-Up  |  Log-In
Current portfolio
"Truth is born of arguments" - a beautiful humanistic motto of Locust (alias Mark Van Hoen) is a best audio illustration of pyramidal portfolio building.
Attention to all members: password to access website was changed to "password". Sorry for some problems with access.
InnoCentive Member Since 2011-12-18
19 Awards for solutions solved
InnoCentive Top Solver for 2013, 2014, 2015, 2016

Biotechs in current portfolio (long is blue and short-term investments are red):

NYMX
CARA (temp. sold for gain)
AKAO
AKBA​​
VBLT
SCLN
OSIR (added more, pps can spike +50%)
EXEL
LXRX
OMER
NTLA
ORMP (possible start of Ph3 oral insulin in 2017)
MESO
ARRY
MYGN
OSUR​
NVO​
NDRM
CYTK
IONS
PTCT​​​​​
INCY
KPTI​
AMRN
CERS
NVCR
AVEO
AUPH
VSTM​
SRNE
ZFGN
INFI​​
JUNO​ (01/22/18 acquired by Celgene $87/share)
ZIOP
BLCM
​​
AIMT​


BiotechInvest credo: "Just give me a problem and I will try my best to solve it"
Each biotech company is a Challenge for investors. To solve this Challenge means to answer just one question: is this company technology/approaches/new drugs and etc. based the true scientific ideas or not? ​Each time when I want to invest money in biotech company I must to solve this Challenge. An Award for correct solving of Challenge is a big gain when this biotech company become successful. Incorrectly solved Challenge = huge losses. 
Attention to all who are trying to "help your website to get on first page of Google and increase the number of leads and sales you are getting from your website. Please email us back for full proposal."

This website is non-commercial, it doesn't need "an increasing of number of leads", etc. Please, don't waste your time on writing "proposal e-mails" - such e-mails immediately go to spam box.

New services for 2018

​​Balanced biotech portfolio is always profitable and bring annual gain at least +25-35%. What is balanced portfolio? Is it possible to have it with $10k start money? How it should be changed when your $10k reached $50k? What if you have $100k for start?

In 2018 ​Biotech_Invest will start several paid services like:

​1) evaluations of biotech company’s science basis (will allow to avoid money losses with scam biotechs and even make money on scam biotechs);
​2) selection of biotech companies for portfolios ($10k-100k start money and up to $1-10M);
​3) an evaluation of success probability of Ph3 clinical trials 

Prices for each service are negotiable. ​​
​​